Innovative Thought Leaders Address the 2011 Rocky Mountain Life Science Investor Conference in Denver

Three renowned speakers will present the most innovative research, collaborations and partnerships within the bioscience industry today at the Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC), Thursday, September 22, at the Brown Palace Hotel in Denver. The announcement is made by Holli Riebel (formerly Baumunk), President and CEO of the Colorado BioScience Association (CBSA), who says: "The conference will be attended by leaders of early-stage private and public life science, bioscience investors and strategic partners."

The RMLIPC is the region’s only bioscience conference of its kind. This year’s speakers will discuss new innovative business models to bring emerging technologies to market and develop partnerships for success. “The keynote presenters are crucial thought leaders shaping the future of the bioscience industry,” Riebel said.

The breakfast keynote on Thursday will feature Peter A. Gottlieb, MD, Professor of Pediatrics and Medicine at the University of Colorado Denver and Center Director at the Barbara Davis Center for Childhood Diabetes, and Dennis R. Roop, Ph.D., Director of The Charles C. Gates Center for Regenerative Medicine and Stem Cell Biology at the University of Colorado Anschutz Medical Campus. According to Riebel, the CBSA is honored to present these two thought leaders in the clinical world and the stem cell research arena. Drs. Gottlieb and Roop will share how they look at research philanthropy as a growing model for creating and sustaining university initiatives, including Centers of Excellence, that address critical research needs and potential commercializable opportunities.

The luncheon keynote will feature Roy Davis, President, Johnson & Johnson Corporate Development. Mr. Davis is a returning expert presenter at the conference and will share his presentation “Strategic Value Creation: A Corporate Investor’s View,” including his vision for new partnering research and development strategies and expert insight into current issues affecting the biotechnology industry.

Link to the Business Wire release

Link to the PitchEngine Social Media Release